Literature DB >> 9361299

The nagging question of the function of N-acetylaspartylglutamate.

J T Coyle1.   

Abstract

N-Acetylaspartylglutamate (NAAG) is a neuropeptide found in millimolar concentrations in brain that is localized to subpopulations of glutamatergic, cholinergic, GABAergic, and noradrenergic neuronal systems. NAAG is released upon depolarization by a Ca(2+)-dependent process and is an agonist at mGluR3 receptors and an antagonist at NMDA receptors. NAAG is catabolized to N-acetylaspartate and glutamate primarily by glutamate carboxypeptidase II, which is expressed on the extracellular surface of astrocytes. The levels of NAAG and the activity of carboxypeptidase II are altered in a regionally specific fashion in several neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361299     DOI: 10.1006/nbdi.1997.0153

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  43 in total

1.  The effects of glutamate on spontaneous acetylcholine secretion processes in the rat neuromuscular synapse.

Authors:  A I Malomuzh; M R Mukhtarov; A Kh Urazaev; E E Nikol'skii; F Vyskochil
Journal:  Neurosci Behav Physiol       Date:  2002 Nov-Dec

2.  Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disorders.

Authors:  Laura R Schaevitz; Jonathan D Picker; Jasmine Rana; Nancy H Kolodny; Barry Shane; Joanne E Berger-Sweeney; Joseph T Coyle
Journal:  Dev Neurobiol       Date:  2012-06       Impact factor: 3.964

Review 3.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 4.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

5.  Molecular characterization of N-acetylaspartylglutamate synthetase.

Authors:  Ivonne Becker; Julia Lodder; Volkmar Gieselmann; Matthias Eckhardt
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

6.  ATP-binding Cassette Subfamily C Member 5 (ABCC5) Functions as an Efflux Transporter of Glutamate Conjugates and Analogs.

Authors:  Robert S Jansen; Sunny Mahakena; Marcel de Haas; Piet Borst; Koen van de Wetering
Journal:  J Biol Chem       Date:  2015-10-29       Impact factor: 5.157

7.  The maize d2003, a novel allele of VP8, is required for maize internode elongation.

Authors:  Hongkun Lv; Jun Zheng; Tianyu Wang; Junjie Fu; Junling Huai; Haowei Min; Xiang Zhang; Baohua Tian; Yunsu Shi; Guoying Wang
Journal:  Plant Mol Biol       Date:  2013-11-09       Impact factor: 4.076

Review 8.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

9.  Excitatory neurotransmitters in brain regions in interictal migraine patients.

Authors:  Andrew Prescot; Lino Becerra; Gautam Pendse; Shannon Tully; Eric Jensen; Richard Hargreaves; Perry Renshaw; Rami Burstein; David Borsook
Journal:  Mol Pain       Date:  2009-06-30       Impact factor: 3.395

10.  GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.

Authors:  Emilio R Garrido Sanabria; Krystyna M Wozniak; Barbara S Slusher; Asaf Keller
Journal:  J Neurophysiol       Date:  2003-08-13       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.